Ability
Developer of modulating biotherapeutics to address cancer and autoimmune diseases
Funding snapshot
About
Developer of modulating biotherapeutics to address cancer and autoimmune diseases. It has AbiLeap discovery engine that combines continuously learning AI with an extensive database of antigen-antibody interactions to generate fully human, IgG-based multispecific antibodies across cancer and autoimmune applications. The pipeline includes Leap 1121 for auti-immune disease, Leap 1009 and 1030 for solid tumors.
Latest news
No articles yet.
Similar startups
PayFlow
Embedded payments infrastructure for Southeast Asian marketplaces and platforms.
NovaHealth AI
Clinical documentation copilot for ambulatory care networks in the US.
GreenGrid
Software for planning and operating distributed battery storage across Europe.
HyperVerge
Provider of end-to-end KYC software and identity verification solutions